Precision Medicine in Oncology® | Specialty

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

From Bedside to Bench

November 29th 2014

Based on a current laboratory research project, Zarah Dulce F. Lucas, MD, discusses microRNAs and their potential to predict brain metastases in patients with triple-negative and HER2-positive breast cancer.

PARP Inhibitors for Breast and Ovarian Cancers

November 26th 2014

PARP inhibitors represent an exciting new class of anticancer agents and are currently being evaluating in phase III for a number of different indications.

Challenges for the Future of Gynecologic Cancers

November 26th 2014

Emerging Therapies in Cervical Cancer

November 26th 2014

Bevacizumab in Recurrent Metastatic Cervical Cancer

November 26th 2014

Cervical Cancer Screening and Prevention

November 26th 2014

Promising Treatments in Ovarian Cancer

November 26th 2014

Bevacizumab in Ovarian Cancer

November 26th 2014

Platinum Resistance in Ovarian Cancer

November 26th 2014

CA-125 Testing in Ovarian Cancer

November 26th 2014

Intraperitoneal Chemotherapy in Ovarian Cancer

November 26th 2014

Antiangiogenic Agents in Ovarian Cancer

November 26th 2014

Treatment Options in Ovarian Cancer

November 26th 2014

Chemotherapy Regimens for Ovarian Cancer

November 26th 2014

Goal of Surgery in Ovarian Cancer

November 26th 2014

Cytoreductive Surgery for Ovarian Cancer

November 26th 2014

Neoadjuvant Chemotherapy for Ovarian Cancer

November 26th 2014

Timing of Oophorectomy in Ovarian Cancer

November 26th 2014

Prophylactic Oophorectomy for Reducing Ovarian Cancer Risk

November 26th 2014

Universal Screening for BRCA1 and BRCA2 Mutations

November 26th 2014